Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
HTRF Assay from US Patent US20240018153: "BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF"
Assay data:11 Active, 11 Activity ≤ 1 µM, 11 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
In Vitro Kinase Detection Assay from US Patent US20240018147: "SALT OF COMPOUND FOR DEGRADING BTK, CRYSTAL FORM THEREOF, AND USE THEREOF IN MEDICINE"
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
IC50 value on BTK wt/C481S Kinase Inhibition from US Patent US20240002387: "METHOD FOR PREPARING BTK DEGRADING AGENT"
BTK Enzyme Activity Assay from US Patent US20240002377: "PYRROLOPYRIDINE COMPOUND AND APPLICATION THEREOF"
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
In Vitro BTK Kinase Assay from US Patent US11858926: "Inhibiting agents for bruton's tyrosine kinase"
Assay data:144 Active, 95 Activity ≤ 1 nM, 144 Activity ≤ 1 µM, 144 Tested
Kinase Assay from US Patent US20230406856: "SUBSTITUTED PYRROLO [2, 3-b] PYRIDINE AND PYRAZOLO [3, 4-b] PYRIDINE DERIVATIVES AS PROTEIN KINASE INHIBITORS"
Assay data:2 Active, 1 Activity ≤ 1 nM, 2 Activity ≤ 1 µM, 2 Tested
ADP-Glo Kinase Biochemical Assay from US Patent US11840513: "Substituted nicotinimide inhibitors of BTK for treating cancer"
Assay data:53 Active, 62 Activity ≤ 1 µM, 62 Tested
Biochemical BTK Assay from US Patent US20230382916: "HETEROARYL HETEROCYCLIC COMPOUNDS AND USES THEREOF"
Assay data:6 Active, 6 Activity ≤ 1 µM, 6 Tested
BTK Kinase Activity Inhibition Test in Vitro from US Patent US20230364079: "COMPOUND AS BRAIN-PERMEABLE BTK OR HER2 INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF"
Assay data:142 Active, 152 Activity ≤ 1 µM, 152 Tested
BTK Enzyme Activity Assay from US Patent US20230357248: "PYRROLOPYRIMIDINE COMPOUND AS BTK INHIBITOR AND USE THEREOF"
Inhibitory Assay from US Patent US11786608: "Isoquinolinyl triazolone complexes"
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
BTK Kinase Assay from US Patent US11739090: "Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitors"
Assay data:10 Active, 2 Activity ≤ 1 nM, 10 Activity ≤ 1 µM, 10 Tested
Inhibition of Btk Enzymatic Activity Assay from US Patent US11673868: "Amino pyrimidine derivatives"
Assay data:40 Active, 13 Activity ≤ 1 nM, 40 Activity ≤ 1 µM, 40 Tested
Determination of Biochemical BTK from US Patent US11655254: "Substituted piperazines as BTK inhibitors"
Biological Assay from US Patent US11623921: "Indole carboxamide compounds"
Assay data:223 Active, 91 Activity ≤ 1 nM, 223 Activity ≤ 1 µM, 223 Tested
In Vitro Kinase Detection from US Patent US11542266: "Substituted piperidines as BTK inhibitors"
BTK and EGFR in Vitro Assay from US Patent US11542249: "BTK inhibitor compounds"
Assay data:47 Active, 47 Activity ≤ 1 µM, 47 Tested
Selectivity interaction (KinomeScan (DiscoverX, competition-binding assay)) EUB0000353a BTK
Assay data:1 Tested
SummaryRelated BioAssays by Target
Selectivity interaction (Enzymatic assay) EUB0000624a BTK
Affinity Biochemical interaction (33P-ATP and filter-binding assay (Reaction Biology)) EUB0000646a BTK
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on